SCHEMBL31041745

SCHEMBL31041745

CNCCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ APLNR P35414 2/20 0.36
▸ C5AR1 P21730 2/20 0.35
▸ NPY1R P25929 1/20 0.34
▸ NPY2R P49146 1/20 0.34
▸ NPY4R P50391 1/20 0.34
▸ FNTA P49354 6/20 0.34
▸ FNTB P49356 6/20 0.34
▸ PGGT1B P53609 6/20 0.34
▸ GLP1R P43220 2/20 0.34
▸ F2 P00734 2/20 0.34
▸ SCTR P47872 1/20 0.34
▸ CALCR P30988 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31041731 0.91 SLC15A2 (0.38) APLNRC5AR1CALCR
SCHEMBL31041733 0.91 SLC15A2 (0.38) APLNRC5AR1CALCR
SCHEMBL31041739 0.90 EED (0.38) APLNRC5AR1NPY1RNPY2RNPY4R
SCHEMBL31041714 0.90 APLNR (0.34) APLNRC5AR1NPY1RNPY2RNPY4R
SCHEMBL31041679 0.86 SLC15A2 (0.37) APLNRC5AR1CALCR
SCHEMBL31041750 0.86 CALCR (0.39) APLNRC5AR1GLP1RCALCR
SCHEMBL31573788 0.84 FOLH1 (0.36) APLNRFNTAFNTBPGGT1B
SCHEMBL31041699 0.83 SLC15A2 (0.41) APLNRC5AR1NPY1RNPY2RNPY4R
SCHEMBL31041694 0.83 SLC15A2 (0.41) APLNRC5AR1NPY1RNPY2RNPY4R
SCHEMBL29630656 0.82 DPP4 (0.35) C5AR1NPY1RNPY2RNPY4RF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118184747-A Polypeptide with breast cancer resisting activity and application thereof 苏州青锐生物科技有限公司 2024-06-14 — — CN claimed
CN-118184747-A Polypeptide with breast cancer resisting activity and application thereof 苏州青锐生物科技有限公司 2024-06-14 — — CN disclosed
Send feedback